Laurus Labs Invests ₹107.8 Crore In KRKA Pharma, Maintains 49% Stake
Mumbai: Laurus Labs Limited has invested ₹107.8 crore in KRKA Pharma Private Limited through a rights issue, according to a company announcement dated October 14, 2026. The pharmaceutical company acquired 10.78 crore equity shares with a face value of ₹10 each. The investment follows an earlier intimation submitted on April 30, 2026, linking the latest disclosure to its previously communicated…
Mumbai: Laurus Labs Limited has recently committed ₹107.8 crore to KRKA Pharma Private Limited through a rights issue, according to an October 14, 2026 announcement. The pharmaceutical company acquired 10.78 crore equity shares, each with a face value of ₹10. This investment occurs following a previous disclosure made on April 30, 2026, linking it to the company's investment plans.
The transaction results in Laurus Labs maintaining its 49% stake in the joint venture. Following the investment, Laurus Labs' total holding in KRKA Pharma stands at 26.215 crore equity shares.
Written by urgent.news from Free Press Journal's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
